Cargando…

A PREALBUMIN ACTIVATOR OF PREKALLIKREIN : II. DERIVATION OF ACTIVATORS OF PREKALLIKREIN FROM ACTIVE HAGEMAN FACTOR BY DIGESTION WITH PLASMIN

Activation of a plasma fraction containing unactivated Hageman factor and prekallikrein followed by chromatography of this fraction on DEAE-cellulose revealed four peaks having bradykinin-generating activity. Peak 1 contained kallikrein; peaks 2–3, 4, and 5 each contained prekallikrein-activating ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplan, Allen P., Austen, K. Frank
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1971
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138966/ https://www.ncbi.nlm.nih.gov/pubmed/4251126

Ejemplares similares

A PREALBUMIN ACTIVATOR OF PREKALLIKREIN : III. APPEARANCE OF CHEMOTACTIC ACTIVITY FOR HUMAN NEUTROPHILS BY THE CONVERSION OF HUMAN PREKALLIKREIN TO KALLIKREIN
por: Kaplan, Allen P., et al.
Publicado: (1972)

PREKALLIKREIN DEFICIENCY IN MAN
por: Wuepper, Kirk D.
Publicado: (1973)

PLASMA PREKALLIKREIN: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION
por: Wuepper, Kirk D., et al.
Publicado: (1972)

Development of an updated assay for prekallikrein activator in albumin and immunoglobulin therapeutics
por: Roberts, Graham, et al.
Publicado: (2020)

Diagnostic Pearls and Clinical Implications of Prekallikrein Deficiency
por: Yasin, Hassaan, et al.
Publicado: (2020)

Combined occurrence of Bernard-Soulier syndrome and prekallikrein deficiency
por: Shahverdi, Ehsan, et al.
Publicado: (2017)

Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency
por: Dasgupta, Swapan K., et al.
Publicado: (2020)

The Involvement of Proteoglycans in the Human Plasma Prekallikrein Interaction with the Cell Surface
por: Veronez, Camila Lopes, et al.
Publicado: (2014)

Plasma Prekallikrein: Its Role in Hereditary Angioedema and Health and Disease
por: Schmaier, Alvin H.
Publicado: (2018)

Association Between Prekallikrein and Stroke: A Mendelian Randomization Study
por: Wang, Yinan, et al.
Publicado: (2023)

Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo
por: Chen, Zu-Lin, et al.
Publicado: (2022)

Severe Prekallikrein Deficiency Associated with Low Level of Factor XII: A Case Report
por: Shahbazi, Massoumeh, et al.
Publicado: (2021)

IONIS-PKK(Rx) a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production
por: Ferrone, Jason D., et al.
Publicado: (2019)

Prekallikrein Deficiency Presenting as Recurrent Cerebrovascular Accident: Case Report and Review of the Literature
por: Bojanini, Esteban Uribe, et al.
Publicado: (2012)

Homozygous Prekallikrein Deficiency in the USA: Several Patients but Still Few Mutation Studies
por: Girolami, Antonio, et al.
Publicado: (2021)

Modulation of Neuro-Inflammatory Signals in Microglia by Plasma Prekallikrein and Neuronal Cell Debris
por: Jaffa, Aneese A., et al.
Publicado: (2021)

A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System
por: Riano, Ivy, et al.
Publicado: (2021)

Prekallikrein inhibits innate immune signaling in the lung and impairs host defense during pneumosepsis in mice
por: Ding, Chao, et al.
Publicado: (2019)

Circulating prekallikrein levels are correlated with lipid levels in the chinese population: a cross-sectional study
por: Shu, Yuanlu, et al.
Publicado: (2023)

The First Case of Congenital Prekallikrein Deficiency in Korea With a Novel Pathogenic Variant (c.1198G>T)
por: Ryu, Sohee, et al.
Publicado: (2019)

Prevalence of Cardiovascular Disorders in African-Americans With Congenital Prekallikrein Deficiency Versus Caucasians-Americans With the Same Defect
por: Girolami, Antonio, et al.
Publicado: (2020)

The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis
por: Fijen, Lauré M., et al.
Publicado: (2022)

Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States
por: Girolami, Antonio, et al.
Publicado: (2020)

Diagnostic and prognostic role of circulating neutrophil extracellular trap markers and prekallikrein in patients with high-grade serous ovarian cancer
por: Kim, Jisoo G., et al.
Publicado: (2022)

Activation of the classical pathway of complement by Hageman factor fragment
Publicado: (1981)

PATHOGENESIS OF INFLAMMATION : II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ
por: Graham, Richard C., et al.
Publicado: (1965)

SUBSTRATES OF HAGEMAN FACTOR : I. Isolation and Characterization of Human Factor XI (PTA) and Inhibition of the Activated Enzyme by α(1)-Antitrypsin
por: Heck, Louis W., et al.
Publicado: (1974)

Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing
por: Gindele, Réka, et al.
Publicado: (2021)

The autoactivation of rabbit hageman factor
por: Wiggins, RC, et al.
Publicado: (1979)

ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
por: Cochrane, C. G., et al.
Publicado: (1973)

DIRECT EVIDENCE FOR HAGEMAN FACTOR (FACTOR XII) ACTIVATION BY BACTERIAL LIPOPOLYSACCHARIDES (ENDOTOXINS)
por: Morrison, David C., et al.
Publicado: (1974)

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma
Publicado: (1978)

Factor XII (Hageman) Levels in Women with Recurrent Pregnancy Loss
por: Ozgu-Erdinc, A. Seval, et al.
Publicado: (2014)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

Does plasmin have anticoagulant activity?
por: Hoover-Plow, Jane
Publicado: (2010)

Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity—A Review
por: Kolodziejczyk-Czepas, Joanna, et al.
Publicado: (2023)

Factor XII (Hageman Factor) Deficiency: a rare harbinger of life threatening complications
por: Chaudhry, Liaqat Ali, et al.
Publicado: (2019)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITRO : THE ROLE OF HAGEMAN FACTOR, A CLOT-PROMOTING AGENT
por: Donaldson, Virginia H.
Publicado: (1968)

Plasmin Activation of Glial Cells through Protease-Activated Receptor 1
por: Greenidge, André R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kmi5tjg549vajbnsjl47q1uqfa